Advanced Oncotherapy plc Share Price
Equities
AVO
GB00BD6SX109
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.925 GBX | -.--% | +10.00% | +10.00% |
02/04 | Sareum ups retail offer; SThree nabs former ITV exec | AN |
29/02 | EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding | AN |
Sales 2020 | - | Sales 2021 | - | Capitalization | 172M 14.31B |
---|---|---|---|---|---|
Net income 2020 | -25M -2.08B | Net income 2021 | -29M -2.42B | EV / Sales 2020 | - |
Net Debt 2020 | 48.32M 4.03B | Net Debt 2021 | 49.09M 4.09B | EV / Sales 2021 | - |
P/E ratio 2020 |
-4.11
x | P/E ratio 2021 |
-4.93
x | Employees | 174 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 52.47% |
1 week | +10.00% | ||
Current month | +10.00% | ||
1 month | +10.00% | ||
3 months | +10.00% | ||
6 months | +10.00% | ||
Current year | +10.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 27/14/27 | |
Director of Finance/CFO | - | 01/16/01 | |
Michael Sinclair
CHM | Chairman | 82 | 16/06/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lori Jo Cross
BRD | Director/Board Member | 64 | 29/20/29 |
Michael Sinclair
CHM | Chairman | 82 | 16/06/16 |
Hans von Celsing
BRD | Director/Board Member | 74 | 26/17/26 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.00% | 11.83M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- AVO Stock